Product Program year 2025 Source: CMS Open Payments

Diamondback Coronary

Device Vascular

PDI 10852528005169

Open in the dashboard

General payments

$874,195

5,216 payments

Research payments

$1,669,490

327 payments

Through program year 2025, $874,195 in general payments and $1,669,490 in research payments were reported against Diamondback Coronary (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $197,820 1,237
2024 General $276,421 1,748
2024 Research $923,232 171
2023 General $399,955 2,231
2023 Research $746,258 156

Breakdown

Who paid General payments · program years 2023–2025
  1. Abbott Laboratories $874,195 5,216 payments
Top recipients General payments · program year 2025
  1. Antonis Pratsos Interventional Cardiology · Broomall, PA $17,373 9% · 13 payments
  2. Sean Janzer Interventional Cardiology · York, PA $15,861 8% · 22 payments
  3. Sarang Mangalmurti Cardiovascular Disease · Bryn Mawr, PA $14,623 7% · 10 payments
  4. James Park Emergency Medicine · Urbana, IL $14,450 7% · 7 payments
  5. Thomas McGarry Interventional Cardiology · Oklahoma City, OK $14,359 7% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $121,978 63% · 288 practitioners
  2. Cardiovascular Disease Internal Medicine $42,569 22% · 178 practitioners
  3. Emergency Medicine $14,984 8% · 6 practitioners
  4. Internal Medicine $4,483 2% · 50 practitioners
  5. Family Medicine $3,631 2% · 2 practitioners

The top 5 of 50 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $50,282 25% · 39 recipients
  2. Florida $27,524 14% · 69 recipients
  3. Ohio $16,194 8% · 43 recipients
  4. Illinois $14,773 7% · 11 recipients
  5. Oklahoma $14,422 7% · 3 recipients

The top 5 of 44 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

5,216 general · 327 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record